INTELLIGENT BIO SOLUTIONS INC. Revenue
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Revenue of $902.14 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2025-05-13
- INTELLIGENT BIO SOLUTIONS INC. revenues for the quarter ending 2025-03-31 was $902.14K, a 0.61% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. revenues for the quarter ending 2024-12-31 was $741.13K, a 19.20% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. revenues for the quarter ending 2024-09-30 was $998.41K, a 10.20% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. revenues for the quarter ending 2024-03-31 was $907.64K.
- INTELLIGENT BIO SOLUTIONS INC. revenues for fiscal 2021 was $1.98M, a 949.30% increase from fiscal 2020.
- INTELLIGENT BIO SOLUTIONS INC. revenues for fiscal 2020 was $188.74K.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2025-03-31 | $902.14K 10-Q · filed 2025-05-13 | $1.64M derived: sum of 2 quarters · filed 2025-05-13 | $2.64M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $741.13K 10-Q · filed 2025-02-13 | $1.74M 10-Q · filed 2025-02-13 | ||
| 2024-09-30 | $998.41K 10-Q · filed 2024-11-07 | |||
| 2024-03-31 | $907.64K 10-Q · filed 2025-05-13 | $1.82M derived: sum of 2 quarters · filed 2025-05-13 | $2.73M 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $917.27K 10-Q · filed 2025-02-13 | $1.82M 10-Q · filed 2025-02-13 | ||
| 2023-09-30 | $905.97K 10-Q · filed 2024-11-07 | |||
| 2021-12-31 | $177.79K 10-Q · filed 2022-02-11 | $177.79K 10-Q · filed 2022-02-11 | ||
| 2021-06-30 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | $1.64M derived: sum of 2 quarters · filed 2021-09-16 | $1.93M derived: sum of 3 quarters · filed 2022-02-11 | $1.98M 10-K · filed 2021-09-16 |
| 2021-03-31 | $34.29K 10-Q · filed 2021-05-13 | $317.33K derived: sum of 2 quarters · filed 2022-02-11 | $372.75K 10-Q · filed 2021-05-13 | $441.75K derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-12-31 | $283.04K 10-Q · filed 2022-02-11 | $338.46K 10-Q · filed 2022-02-11 | $407.46K derived: sum of 3 quarters · filed 2022-02-11 | $405.93K derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-09-30 | $55.43K 10-Q · filed 2021-11-12 | $124.43K derived: sum of 2 quarters · filed 2021-11-12 | $122.89K derived: sum of 3 quarters · filed 2021-11-12 | $122.10K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | $67.47K derived: sum of 2 quarters · filed 2021-09-16 | $66.67K derived: sum of 3 quarters · filed 2021-09-16 | $188.74K 10-K · filed 2021-09-16 |
| 2020-03-31 | -$1.53K 10-Q · filed 2021-05-13 | -$2.33K derived: sum of 2 quarters · filed 2021-05-13 | $119.74K 10-Q · filed 2021-05-13 | |
| 2019-12-31 | -$798.00 10-Q · filed 2021-02-12 | $121.28K 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |